Scientists correct a longstanding misconception about the origins of Barrett's esophagus, and in doing so may point to new avenues of treatment or prevention to lower the risk of esophageal cancer.
Related topics: Medical Research, Cancer, Oncology
Researchers at the University of Szeged in Hungary have demonstrated for the first time that an esophagus organoid successfully duplicates a vital function of that organ. This function, ion transport, is known to play a role in esophageal cancer and...
Related topics: Cancer, Oncology, Medical Research
Coherus BioSciences, Inc. CHRS and its partner Shanghai Junshi Biosciences Co., Ltd. have announced that the FDA has granted an Orphan Drug designation to their anti-PD-1 antibody, toripalimab, for the treatment of esophageal cancer...
Related topics: Food And Drug Administration, Cancer, Oncology
There is an urgent need for innovation in cancer treatments. Although we’ve seen significant progress in indications for drugs treating particular diseases, cancer research data shows that 10-year survival statistics for cancers such as...
Related topics: Cancer, Lung Cancer, Oncology, Medical Research
(MedPage Today) -- Patients at community oncology centers had high expectations for genomic tumor testing in association with limited understanding of how the tests work. (JCO Precision Oncology)
A doctor who spent a year hoping to make a...
Related topics: Cancer, Cervical Cancer, Genomics, Genetics, Oncology, Lawsuits
Agilent Technologies A has bolstered presence in the clinical and diagnostic testing market of Europe by expanding the use of PD-L1 IHC 22C3 pharmDx assay in patients suffering from esophageal cancer in the continent.The assay will enable...
Related topics: AGILENT (A), Cancer, Oncology
(MedPage Today) -- Concurrent chemoradiotherapy (CRT) with the oral fluoropyrimidine S-1 was both effective and tolerable in older patients with esophageal cancer, according to a randomized phase III trial.
The 2-year overall survival (OS) rate...
Related topics: Cancer, Oral Cancer, Oncology
(MedPage Today) -- Overall survival (OS) in previously treated esophageal cancer improved significantly with the anti-PD-1 drug tislelizumab compared to chemotherapy, a phase III, randomized trial showed.
Patients randomized to tislelizumab had...
Related topics: Cancer, Oncology, Chemotherapy
(MedPage Today) -- Perioperative chemotherapy in locally advanced esophageal or gastroesophageal junction (GEJ) adenocarcinoma was not "unacceptably" inferior to neoadjuvant chemoradiotherapy, an interim analysis of the randomized Neo-AEGIS trial...
Related topics: Chemotherapy, Cancer, Oncology
(MedPage Today) -- Immunotherapy-containing combinations significantly improved survival in advanced esophageal cancer as compared with standard chemotherapy, a large randomized trial showed.
Median overall survival (OS) in patients with PD-L1...
Related topics: Cancer, Oncology, Chemotherapy
(MedPage Today) -- FDA added another indication for nivolumab (Opdivo) on Thursday, with the PD-1 immune checkpoint inhibitor now approved as an adjuvant treatment for esophageal and gastroesophageal junction (GEJ) cancers.
Nivolumab is...
Related topics: Cancer, Oncology, Food And Drug Administration
Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
Related topics: Cancer, Oncology, Genetics, DNA
People who find themselves reaching for antacid several times a month, might consider reaching out to their doctor instead. Gastroesophageal reflux disease (GERD), the same condition that causes heartburn, is also linked to a deadly form of...
Related topics: Cancer, Oncology
Sunday Burquest, a contestant on Survivor: Millenials vs. Gen X, passed away on Sunday morning after a battle with esophageal and ovarian cancer,
She was 50 years old.
The former reality star had previously been diagnosed with breast cancer in...
Related topics: Breast Cancer, Cancer, Ovarian Cancer, Oncology
”I'm making this public to raise awareness for people to pay attention to symptoms of stomach and esophageal issues,” Hunting says. ”If they persist, please go get it checked out.” Continue reading…
Related topics: Cancer, Oncology
THURSDAY, April 1, 2021 -- Among patients with resected esophageal or gastroesophageal junction cancer who have received neoadjuvant chemoradiotherapy, disease-free survival is significantly longer with nivolumab adjuvant therapy versus placebo,...
Related topics: Cancer, Oncology, Placebo
A combination of esophageal brushing and extensive genetic sequencing of the sample collected can detect chromosome alterations in people with Barrett's Esophagus, identifying patients at risk for progressing to esophageal cancer, according to a new...
Related topics: Cancer, Oncology, Genetics, Chromosomes, Medical Research
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Get Free Report Merck & Co., Inc. (MRK): Free Stock Analysis...
Related topics: Merck & Co, Food And Drug Administration, Cancer, Oncology, Medical Research, Pfizer
Neoadjuvant chemoradiation plus esophagectomy can be performed safely in well-selected older patients with locally advanced esophageal or esophagogastric junction cancer, according to a review Medscape Medical News
Related topics: Cancer, Oncology
FRIDAY, Feb. 26, 2021 -- Patients 70 years and older with locally advanced esophageal or esophagogastric junction (EGJ) cancer should be considered for optimal, potentially curative therapy, including neoadjuvant chemoradiotherapy and surgical...
Related topics: Cancer, Oncology